Communiqués Kinarus Therapeutics Holding AG

Actions

CURE

CH0009115129

Temps réel estimé Cboe Europe Autres places de cotation 12:19:35 11/06/2024			Varia. 5j.	Varia. 1 janv.
6,66 ^CHF	-3,48 %		+2,68 %	+254,91 %

26/04	Bourse Zurich: le SMI se maintient dans le vert avant l'inflation US	AW
26/04	Bourse Zurich: rebond dans les premiers échanges, l'inflation US attendue	AW

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Business Combination of Kinarus Therapeutics Holding AG (now renamed to Curatis Holding AG) and Curatis AG completed	26/04	EQ
Kinarus Therapeutics : Q&A on the Reverse Share Split	17/04	PU
Kinarus Therapeutics : Q&A on the Reverse Share Split” unter Financial News / Corporate News ablegen	17/04	PU
Kinarus Therapeutics Holding AG publishes FY2023 Financial Statements and announces details on Business Combination with Curatis AG and Reverse Share Split	17/04	EQ
Extraordinary General Meeting of Kinarus Holding approved all resolutions relating to the envisaged Business Combination with Curatis	01/03	EQ
Publication of unaudited financial statements of Kinarus Therapeutics Holding AG (only) for FY2023	28/02	EQ
Courts of Basel-Stadt have revoked bankruptcy of Kinarus Therapeutics Holding AG	06/02	EQ
Kinarus Therapeutics Holding AG in Liquidation and Curatis AG propose to combine companies and reverse bankruptcy procedures of Kinarus Therapeutics Holding AG in Liquidation	29/01	EQ
Kinarus Therapeutics has decided to file for bankruptcy	25/09/23	EQ
Kinarus Therapeutics Group Reports First Half 2023 Financial Results	30/08/23	EQ
Kinarus Therapeutics signed licensing agreement to extend cash for operations	25/08/23	EQ
Kinarus Therapeutics : July 2023 Investor Presentation	19/07/23	PU
Kinarus Therapeutics Announces Personnel Changes	12/07/23	EQ
Kinarus Therapeutics Announces Personnel Change	12/07/23	AQ
Kinarus Therapeutics Shareholders Approve All Board Proposals at the 2023 Annual General Meeting	29/06/23	EQ
Kinarus Therapeutics Shareholders Approve All Board Proposals at the 2023 Annual General Meeting	29/06/23	AQ
Kinarus Therapeutics signed subordinated bridge loans to ensure further liquidity	27/06/23	EQ
Kinarus Therapeutics signed subordinated bridge loans to ensure further liquidity	27/06/23	AQ
Kinarus Therapeutics Publishes Invitation to the 2023 Annual General Meeting	02/06/23	EQ
Kinarus Therapeutics Publishes Invitation to the 2023 Annual General Meeting	02/06/23	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Kinarus Therapeutics Holding AG

Actions

CURE

CH0009115129

Communiqués

Filtres